A Year in Review of Antibody-Drug Conjugates for Breast Cancer: Trends, Practice, and Outlook

Join the experts for all you need to know about antibody-drug conjugates (ADCs) in breast cancer.    Credit available for this activity expires: 2/28/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002233?ecd=bdc_podcast_libsyn_mscpedu